Showing results (3221-3230 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|August 11, 2004
Mechanism of inhibition of the human immunodeficiency virus type 1 by the oxygen radical generating agent bleomycinNiki A Georgiou, Tjomme van der Bruggen, Maroeska Oudshoorn, et al.Antiviral Research|August 11, 2004
Tenofovir primes rhesus macaque cells in vitro for enhanced interleukin-12 secretionKoen K A Van Rompay, Marta L Marthas, Norbert BischofbergerAntiviral Research|March 11, 1992
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalisM Lebwohl, S Sacks, M Conant, et al.Antiviral Research|January 18, 2005
The non-nucleoside antiviral, BAY 38-4766, protects against cytomegalovirus (CMV) disease and mortality in immunocompromised guinea pigsMark R Schleiss, David I Bernstein, Michael A McVoy, et al.Antiviral Research|February 15, 2005
Characterization of viral proteins encoded by the SARS-coronavirus genomeYee-Joo Tan, Seng Gee Lim, Wanjin HongAntiviral Research|February 15, 2005
CpG-DNA protects against a lethal orthopoxvirus infection in a murine modelD G Cerys Rees, Amanda J Gates, Michael Green, et al.Antiviral Research|March 18, 2004
Synergistic drug combinations against the in vitro replication of Coxsackie B1 virusLubomira Nikolaeva-Glomb, Angel S GalabovAntiviral Research|March 18, 2004
A simple assay for determining antiviral activity against Crimean-Congo hemorrhagic fever virusJason Paragas, Chris A Whitehouse, Timothy P Endy, et al.Antiviral Research|March 18, 2004
Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivirAeron C Hurt, Ian G Barr, Gunter Hartel, et al.Antiviral Research|March 18, 2004
Opportunities for early therapy of respiratory syncytial virus (RSV) infection: what happens before hospitalizationJohn P DeVincenzo, Jody B Aitken, Lisa G HarrisonPageof 523